Repligen (RGEN) EBT Growth (5y) (2015 - 2026)
Powered by 
Analysis
Repligen (RGEN) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.43% |
| Mar 31, 2026 | -44.32% |
| Dec 31, 2025 | 23.60% |
| Sep 30, 2025 | -0.72% |
| Jun 30, 2025 | 2.60% |
| Mar 31, 2025 | -5.74% |
| Dec 31, 2024 | -90.70% |
| Sep 30, 2024 | -21.86% |
| Jun 30, 2024 | -1.26% |
| Mar 31, 2024 | -18.88% |
| Dec 31, 2023 | 31.24% |
| Sep 30, 2023 | 11.44% |
| Jun 30, 2023 | 49.21% |
| Mar 31, 2023 | 32.31% |
| Dec 31, 2022 | 102.69% |
| Sep 30, 2022 | 91.08% |
| Jun 30, 2022 | 74.87% |
| Mar 31, 2022 | 70.69% |
| Dec 31, 2021 | 85.98% |
| Sep 30, 2021 | 79.48% |